Trafficking kinesin-binding protein 1 or O-Linked N-Acetylglucosamine Transferase Interacting Protein 106 is encoded by the gene TRAK1. TRAK1 is involved in mitochondrial motility and regulation of endosome-to-lysosome trafficking. TRAK1 can bind both kinesin and dynein. TRAK1 is ubiquitously expressed in tissues. Diseases associated with this gene include Early Infantile Epileptic Encephalopathy and Undetermined Early-Onset Epileptic Encephalopathy.
Purified by Protein A chromatography
ICC, IHC, WB
TRAK1 KIAA1042 OIP106
Fusion protein amino acids 1-110 (N-terminus) of human TRAK1 (accession number Q9UPV9) produced recombinantly in E. Coli
Aliquot and store at ≤ -20°C for long term storage. For short term storage, store at 2-8°C. For maximum recovery of product, centrifuge the vial prior to removing the cap.
Produced by in vitro bioreactor culture of hybridoma line followed by Protein A affinity chromatography. Purified mAbs are >90% specific antibody.
10 mM Tris, 50 mM Sodium Chloride, 0.065% Sodium Azide pH 7.125
Does not cross-react with TRAK2
Each new lot of antibody is quality control tested by IHC on either rat or mouse brain and confirmed to give the expected staining pattern.
These antibodies are to be used as research laboratory reagents and are not for use as diagnostic or therapeutic reagents in humans.
24 months from date of receipt
Shipped on ice packs
Trafficking kinesin-binding protein 1 (106 kDa O-GlcNAc transferase-interacting protein)